Texas HB 562: Relating to warning labels for opioid prescription drugs.

Status: Committee report sent to Calendars (as of 2019-05-01)

State: Texas · Session: 86 · Bill: HB 562

Subjects: Alcoholism & Drug Abuse (I0030), Health--Other Diseases & Medical Conditions (I0383), MEDICINE & PRESCRIPTION DRUGS (S7338), PACKAGING & LABELING REQUIREMENTS (S0339), PHARMACIES & PHARMACISTS (S1192), PHARMACY, TEXAS STATE BOARD OF (V0022)

Sponsors: Thierry, Cortez

View Texas HB 562 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.